Nyqvist Jenny, Parris Toshima Z, Helou Khalil, Sarenmalm Elisabeth Kenne, Einbeigi Zakaria, Karlsson Per, Nasic Salmir, Kovács Anikó
Department of Surgery, Skaraborgs Hospital, Lidköping, Sweden.
Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Breast Cancer Res Treat. 2020 Nov;184(1):221-228. doi: 10.1007/s10549-020-05822-z. Epub 2020 Aug 1.
Multiple primary malignancies (MPMs) caused by breast cancer treatment are well described, but only few studies to date describe which other previous primary malignancies (OPPMs) occur before breast cancer. The purpose of the present study was to evaluate the prevalence of OPPMs in patients with breast cancer between 2007 and 2018 in Western Sweden.
Patient selection was performed using both pathology reports at Sahlgrenska University Hospital (Sweden) and the Swedish Cancer Registry. All newly diagnosed breast cancer patients were screened for presence of OPPM.
In total, 8031 breast cancer patients were diagnosed at Sahlgrenska University Hospital between 2007 and 2018. The prevalence of breast cancer patients with OPPMs (n = 414) increased from on average 2.6% to 8.2% during this 12-year period and ranged from 17 to 59 patients annually. The most striking increase in prevalence was found among the gynecological tumors (endometrium and ovarian adenocarcinomas), malignant melanomas and gastrointestinal malignancies. These findings were validated using data of the Swedish Cancer Registry.
The overall survival rates for cancer patients have improved tremendously during the past 40 years, in part due to individually tailored therapies and screening programs. Our study revealed an increasing trend of OPPMs in breast cancer patients.
乳腺癌治疗导致的多原发性恶性肿瘤(MPMs)已有充分描述,但迄今为止只有少数研究描述了在乳腺癌之前发生的其他既往原发性恶性肿瘤(OPPMs)。本研究的目的是评估2007年至2018年瑞典西部乳腺癌患者中OPPMs的患病率。
使用瑞典哥德堡大学萨赫格伦斯卡大学医院的病理报告和瑞典癌症登记处进行患者选择。对所有新诊断的乳腺癌患者进行OPPMs筛查。
2007年至2018年期间,萨赫格伦斯卡大学医院共诊断出8031例乳腺癌患者。在此12年期间,患有OPPMs的乳腺癌患者患病率(n = 414)从平均2.6%增加到8.2%,每年范围为17至59例患者。在妇科肿瘤(子宫内膜癌和卵巢腺癌)、恶性黑色素瘤和胃肠道恶性肿瘤中发现患病率增加最为显著。这些发现使用瑞典癌症登记处的数据进行了验证。
在过去40年中,癌症患者的总体生存率有了巨大提高,部分原因是个体化定制的治疗方法和筛查计划。我们的研究揭示了乳腺癌患者中OPPMs呈上升趋势。